350 million treatment courses of Coartem® Dispersible have been delivered by Novartis to over 50 countries; saving an estimated >875,000 children lives.¹

>100 million vials of Artesun® have been delivered since 2011; saving an estimated 650,000 lives compared to treatment with quinine.²

68 million courses of seasonal malaria chemoprevention have been delivered to countries in the Sahel in 2017, enough to protect 17 million children. Since the launch of SMC, more than 180 million courses of SPAQ have been distributed in countries implementing this intervention.

Two rectal artesunate suppository products for pre-referral management of severe malaria (from Cipla and Strides Shasun) have received WHO prequalification and/or Global Fund ERP approval, permitting procurement by international donors; to-date over 500K suppositories have been delivered. 

When one-year-old Inness Kalunga from Mupula, Serenje District in Zambia fell ill with severe malaria, a community health worker administered a quality-assured rectal artesunate suppository. She was then rushed to hospital and given injectable artesunate. When her condition improved, she was discharged and given artemether-lumefantrine, an oral ACT, paracetamol and multivitamins to take home and complete her malaria treatment. Baby Inness received the treatment she needed to save her life.

Read Inness' story

Four-year-old Desmond Oming from Awir in northern Uganda had malaria for the fourth time in his young life and this time it was severe malaria. He was brought to Apac District Hospital, one of 339 health-care facilities in Uganda that received injectable artesunate through the MMV-led Improving Severe Malaria Outcomes project funded by UNITAID.  Desmond received injectable artesunate, followed by an ACT for 3 days. Happy and healthy, he returned home with his mum.

Read Desomond's story

Two-year-old Kamaragi was suffering from high fever when his mother brought him to Luweero Hospital in Uganda. He was diagnosed with severe malaria and given injectable artesunate. The next day he was able to sit upright in bed and his fever had gone. The worry and panic on his mother’s face changed to relief as she realized her son would survive.

Read Kamaragi's story

Three year old Saudat was admitted to Murtala Mohammed Specialist Hospital in Kano state, Nigeria, unconscious, with convulsions and a temperature of 38.9°C. She had severe malaria. Injectable artesunate was administered immediately, and then regularly for a period of 48 hrs. Two days later, Saudat gained consciousness and was put on a regimen of Coartem^® (artemether-lumefantrine), an oral ACT, to fully cure her.

Read Saudat's story

Precious was vomiting and had diarrhoea. He had a high temperature and within a short time became very weak. He was rushed to the General Hospital Okeho, in Ibadan, Oyo State, Nigeria where it was confirmed that he had severe malaria. He was administered injectable artesunate and after 3 days Precious was well enough to be discharged. Following the first dose there was significant improvement and by the time the second and third doses had been administered, he began eating well and taking oral medications.

Read Precious' story